Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors

• Published in: The Journal of biological chemistry 2012-05, Vol.287 (20), p.16801-16811
• Main Authors: Kessl, Jacques J., Jena, Nivedita, Koh, Yasuhiro, Taskent-Sezgin, Humeyra, Slaughter, Alison, Feng, Lei, de Silva, Suresh, Wu, Li, Le Grice, Stuart F.J., Engelman, Alan, Fuchs, James R., Kvaratskhelia, Mamuka
• Format: Article
• Language: English
• Subjects: Adaptor Proteins, Signal Transducing - genetics; Adaptor Proteins, Signal Transducing - metabolism; Allosteric Regulation; Allosteric Regulation - drug effects; Allosteric Regulation - genetics; DNA, Viral - genetics; DNA, Viral - metabolism; HEK293 Cells; HIV Infections - drug therapy; HIV Infections - enzymology; HIV Infections - genetics; HIV Integrase - genetics; HIV Integrase - metabolism; HIV-1; HIV-1 - physiology; Humans; Indoleacetic Acids - chemistry; Indoleacetic Acids - pharmacology; Integrase; Integrase Inhibitors - chemistry; Integrase Inhibitors - pharmacology; Molecular Bases of Disease; Protein Binding - drug effects; Protein-DNA Interaction; Protein-Protein Interactions; Transcription Factors - genetics; Transcription Factors - metabolism; Virus Replication - drug effects; Virus Replication - physiology
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M112.354373

The multifunctional HIV-1 enzyme integrase interacts with viral DNA and its key cellular cofactor LEDGF to effectively integrate the reverse transcript into a host cell chromosome. These interactions are crucial for HIV-1 replication and present attractive targets for antiviral therapy. Recently, 2-(quinolin-3-yl) acetic acid derivatives were reported to selectively inhibit the integrase-LEDGF interaction in vitro and impair HIV-1 replication in infected cells. Here, we show that this class of compounds impairs both integrase-LEDGF binding and LEDGF-independent integrase catalytic activities with similar IC50 values, defining them as bona fide allosteric inhibitors of integrase function. Furthermore, we show that 2-(quinolin-3-yl) acetic acid derivatives block the formation of the stable synaptic complex between integrase and viral DNA by allosterically stabilizing an inactive multimeric form of integrase. In addition, these compounds inhibit LEDGF binding to the stable synaptic complex. This multimode mechanism of action concordantly results in cooperative inhibition of the concerted integration of viral DNA ends in vitro and HIV-1 replication in cell culture. Our findings, coupled with the fact that high cooperativity of antiviral inhibitors correlates with their increased instantaneous inhibitory potential, an important clinical parameter, argue strongly that improved 2-(quinolin-3-yl) acetic acid derivatives could exhibit desirable clinical properties. 2-(Quinolin-3-yl)-acetic-acid derivatives target HIV-1 integrase and inhibit viral replication. The compounds are allosteric integrase inhibitors (ALLINIs) that block integrase interactions with viral DNA and its cellular cofactor LEDGF and cooperatively inhibit HIV-1 replication. ALLINIs block multiple steps of HIV-1 integration. These new properties of ALLINIs will facilitate their further development as potent antiretroviral compounds.